Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limitations in the interpretation of thyroid function tests.

Medicina clinica·2026
Same author

Improved adequacy of levothyroxine treatment in low-risk differentiated thyroid cancer using the 2025 ATA criteria: a multicenter real-world analysis of 1,016 patients.

European thyroid journal·2026
Same author

Enhancing levothyroxine dosing accuracy post-total thyroidectomy using body fat percentage.

Endocrinologia, diabetes y nutricion·2026
Same author

Assessment of levothyroxine therapy adequacy in low-risk differentiated thyroid carcinoma: a multicenter cohort study.

Frontiers in endocrinology·2025
Same author

A synergistic drug combination that aids our battle against anaplastic thyroid carcinoma: a case report and discussion.

Hormones (Athens, Greece)·2025
Same author

Use of thyroid hormones in euthyroid patients with unexplained fatigue: analyses of aggregate data from European national surveys of professional endocrine society members.

Frontiers in endocrinology·2025

Related Experiment Video

Updated: May 22, 2026

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

Microchimerism in graves' disease.

Juan C Galofré1

  • 1Department of Endocrinology and Nutrition, University Clinic of Navarra, University of Navarra, Pio XII 36, 31080 Pamplona, Spain.

Journal of Thyroid Research
|May 12, 2012
PubMed
Summary

Microchimerism, the presence of cells between individuals, is linked to autoimmune diseases. Fetal cells in the mother's thyroid may influence Graves' disease during and after pregnancy.

Area of Science:

  • Immunology
  • Reproductive Biology
  • Endocrinology

Background:

  • Microchimerism involves cells from one individual residing in another.
  • Pregnancy facilitates natural microchimerism via bidirectional cell transfer between mother and fetus.
  • The role of pregnancy-related microchimerism in autoimmune disease development is an active research area.

Purpose of the Study:

  • To investigate the potential link between fetal microchimerism and autoimmune diseases, specifically Graves' disease.
  • To explore the significance of intrathyroidal fetal microchimerism in the context of Graves' disease.

Main Methods:

  • Review of existing literature on microchimerism and autoimmune diseases.
  • Analysis of studies demonstrating fetal microchimeric cells in thyroid glands of patients with Graves' disease.

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Related Experiment Videos

Last Updated: May 22, 2026

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Main Results:

  • A significant number of fetal microchimeric cells have been found in the thyroid glands of patients with Graves' disease.
  • This finding suggests a potential mechanism for how fetal microchimerism influences Graves' disease.

Conclusions:

  • Intrathyroidal fetal microchimerism is a compelling candidate for modulating Graves' disease.
  • Further research is warranted to understand the precise mechanisms and implications during pregnancy and postpartum.